eXoZymes Inc
exozymes.comWhat Do They Do?
Develops cell-free enzyme biosolutions to make natural compounds and analogs for nutraceutical and pharmaceutical markets.
10-K for FY2025, filed Mar 30, 2026All of the aforementioned examples represent very large potential business opportunities. Focusing our efforts will be key. And we will…View ↗
Exozymes are advanced enzymes engineered with the aid of artificial intelligence to function in bioreactors outside of living cells. These…View ↗
As already described, we believe the potential applications of our technology are extensive. We are currently focusing on low-volume…View ↗
How Do They Make Money?
Strategic collaborators pay upfront fees and fund research and development through alliances that may also cover licenses, services, and development or manufacture of materials.
10-K for FY2025, filed Mar 30, 2026The Company primarily generated revenues from its strategic alliances. The strategic alliances with strategic collaborators typically…View ↗
$70.1K
-
10-K for FY2024, filed Mar 31, 2025
$70.1K ↗
Who Are Their Customers?
Strategic collaborators work with eXoZymes through alliances covering research, licenses, development services, and materials; the company expects partners with customer bases and distribution networks to help bring products to market.
10-K for FY2025, filed Mar 30, 2026
Do Revenues Turn Into Profits?
No. It lost $2M in FY2023.
10-K for FY2024, filed Mar 31, 2025
−$1.8MView ↗
10-K for FY2024, filed Mar 31, 2025
−$2MView ↗
10-K for FY2024, filed Mar 31, 2025
−$1.5MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 13, 2026
−$2.9MView ↗
- ▲ +22% (Loss)
- vs −$2.4M in Q2 FY2025
Who Do They Compete With?
Competes with Debut Biotech, Solugen, Codexis, Allozymes, Enzymit, Zymtronix Catalytic Systems, Arzeda, Quantumzyme, Valero Energy, ADM, Cargill, Gevo, Butamax Advanced Biofuels, and Brightseed Bio
10-K for FY2025, filed Mar 30, 2026We believe that we will face competition from many companies and research institutions that are currently working in, and will enter, the…View ↗
Loading...
